Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,258,724 papers from all fields of science
Search
Sign In
Create Free Account
Cutaneous Assessment Tool
Known as:
CAT
An assessment of a wide range of cutaneous manifestations reflecting activity and damage from idiopathic inflammatory myopathy in children and adults…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Research or Clinical Assessment Tool
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Health-related quality of life and its influencing factors in adult patients with localized scleroderma - a cross-sectional study
A. Lis-Święty
,
Alina Skrzypek-Salamon
,
I. Ranosz-Janicka
,
L. Brzezińska-Wcisło
Health and Quality of Life Outcomes
2020
Corpus ID: 218593715
Background Localized Scleroderma (LoS) is an autoimmune connective tissue disease that affects skin and less commonly…
Expand
2018
2018
Detecting and quantifying activity/inflammation in localized scleroderma with thermal imaging
I. Ranosz-Janicka
,
A. Lis-Święty
,
Alina Skrzypek-Salamon
,
Ligia Brzezińska-Wcisło
Skin research and technology
2018
Corpus ID: 51705543
The disease phase in localized scleroderma (LoS) is commonly assessed by clinical investigation using the LoS cutaneous…
Expand
2017
2017
Alternative Scoring of the Cutaneous Assessment Tool ( CAT ) in Juvenile Dermatomyositis : Results Using an Abbreviated Format
A. Huber
,
P. Lachenbruch
,
E. Dugan
,
F. Miller
,
L. Rider
2017
Corpus ID: 40026970
Objectives—The Cutaneous Assessment Tool (CAT) is a comprehensive, semi-quantitative tool for the assessment of skin disease in…
Expand
2016
2016
Comparison of the Utility and Validity of Three Scoring Tools to Measure Skin Involvement in Patients With Juvenile Dermatomyositis
R. Campanilho-Marques
,
Beverley Almeida
,
+85 authors
Helen Pluess‐Hall
Arthritis care & research
2016
Corpus ID: 10618720
To compare the abbreviated Cutaneous Assessment Tool (CAT), Disease Activity Score (DAS), and Myositis Intention to Treat…
Expand
2014
2014
A48: Durometer Measures Discriminate Affected versus Normal Skin in Pediatric Localized Scleroderma
S. Poff
,
Suzanne C. Li
,
C. Kelsey
,
I. Foeldvari
,
K. Torok
2014
Corpus ID: 58226691
Localized scleroderma (LS) is an autoimmune, inflammatory disease of the skin and subdermal tissues, resulting in fibrosis and…
Expand
Review
2012
Review
2012
Morphea and other localized forms of scleroderma
R. Vasquez
,
Chelsea Sendejo
,
H. Jacobe
Current Opinion in Rheumatology
2012
Corpus ID: 6326418
Purpose of reviewMorphea, also known as localized scleroderma, is a disorder of excessive collagen deposition leading to…
Expand
Highly Cited
2008
Highly Cited
2008
Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis
R. Q. Klein
,
Carolyn A. Bangert
,
+11 authors
Victoria P. Werth
British Journal of Dermatology
2008
Corpus ID: 24413130
Background Reliable and validated measures of skin disease severity are needed for cutaneous dermatomyositis (DM). Cutaneous…
Expand
2008
2008
Alternative scoring of the Cutaneous Assessment Tool in juvenile dermatomyositis: results using abbreviated formats.
A. Huber
,
P. Lachenbruch
,
E. Dugan
,
F. Miller
,
L. Rider
Arthritis & Rheumatism
2008
Corpus ID: 8327318
OBJECTIVE The Cutaneous Assessment Tool (CAT) is a comprehensive, semiquantitative tool for the assessment of skin disease in…
Expand
2008
2008
Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositis.
A. Huber
,
E. Dugan
,
+12 authors
L. Rider
Arthritis & Rheumatism
2008
Corpus ID: 12300808
OBJECTIVE To provide preliminary validation of the Cutaneous Assessment Tool (CAT), a new tool to assess cutaneous manifestations…
Expand
2007
2007
The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathy.
A. Huber
,
E. Dugan
,
+13 authors
L. Rider
Rheumatology
2007
Corpus ID: 13761991
OBJECTIVES Clinical care and therapeutic trials in idiopathic inflammatory myopathies (IIM) require accurate and consistent…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required